Full Text
The Full Text of this article is available as a PDF (320.8 KB).
. 2007 Aug 1;7(4):388–391. doi: 10.7861/clinmedicine.7-4-388
Antiplatelet therapy in acute coronary syndromes
Arun Natarajan
1, Ahmar Tarique
1, Azfar G Zaman
1
Arun Natarajan, MRCP
1Department of Cardiology, Freeman Hospital and School of Clinical Medicine, Newcastle University, Newcastle upon Tyne
Specialist Registrar in Cardiology
Find articles by Arun Natarajan
Ahmar Tarique, MBBS
1Department of Cardiology, Freeman Hospital and School of Clinical Medicine, Newcastle University, Newcastle upon Tyne
Fellow in Cardiology
Find articles by Ahmar Tarique
Azfar G Zaman, MD FRCP
1Department of Cardiology, Freeman Hospital and School of Clinical Medicine, Newcastle University, Newcastle upon Tyne
Consultant Cardiologist
Find articles by Azfar G Zaman
1Department of Cardiology, Freeman Hospital and School of Clinical Medicine, Newcastle University, Newcastle upon Tyne
Roles
Arun Natarajan: MRCP, Specialist Registrar in Cardiology
Ahmar Tarique: MBBS, Fellow in Cardiology
Azfar G Zaman: MD FRCP, Consultant Cardiologist
KEY WORDS: acute coronary syndromes, antiplatelet agents, aspirin, dual antiplatelet therapy, glycoprotein IIb/IIIa inhibitors, thienopyridines
© 2007 Royal College of Physicians
PMCID: PMC4952904 PMID: 17882859